RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the closing of the exclusive global license agreement for LM-299, a novel investigational PD-1/VEGF bispecific antibody, from LaNova Medicines Ltd. As previously announced, Merck will develop, manufacture and commercialize LM-...

RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that Surendralal L. “Lal” Karsanbhai, president and chief executive officer, Emerson Electric Co. (NYSE: EMR), will join Merck’s board of directors effective January 1, 2025. He will stand for election by the company’s shareholders...

87.5% of patients treated with LYNPARZA were alive at six-years vs. 83.2% in the comparator arm First and only PARP inhibitor to improve overall survival in early breast cancer RAHWAY, N.J.--(BUSINESS WIRE)-- AstraZeneca and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced long-term result...

RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYLYNK-001 trial evaluating KEYTRUDA ® (pembrolizumab) plus chemotherapy followed by maintenance with LYNPARZA ® (olaparib), with or without bevacizumab, as a first-line treatment for p...

Lavay, New Jersey, December 5, 2024- Merck&Co. (NYSE: MRK), also known as MSD outside of the United States and Canada, ranked first for the second consecutive year on Newsweek's annual list of the most responsible companies in the United States. Merck Chairman and CEO Robert M. Davis said, "We strictly adhere to the highest ethical and integrity stand...

Merck has signed a donation agreement with the China Cancer Foundation for the Comprehensive Prevention and Control of Cervical Cancer in Low Health Resource Areas of China, focusing on accelerating the elimination of cervical cancer. Merck plans to donate a total of 81000 HPV vaccines to the China Cancer Foundation in the next two years, to provide free vac...

Recently, Merck&Co., Inc., a well-known multinational pharmaceutical and life science company in the United States, called "MSD" in Chinese Mainland, announced that its handheld mall has officially entered the Chinese Mainland region. This strategic initiative aims to provide Chinese users with a more convenient and efficient experience of understanding ...

Merck Mobile Mall in the United States has reached a financial cooperation agreement with Ping An Property&Casualty Insurance Company in China Recently, Merck&Co., Inc., a well-known pharmaceutical and life science company in the United States, announced that its "Mobile Merck Mall" has reached a strategic cooperation agreement with Ping An Property...

RAHWAY, N.J., Sept. 26, 2024 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the outcomes of today’s U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting. The meeting was convened to discuss the risk-benefit assessment of the use of immune checkpoint inhibitors, including K...

RAHWAY, N.J., Nov. 20, 2024 – The Merck Foundation (Foundation), a private charitable organization funded by Merck (NYSE: MRK), known as MSD outside of the United States and Canada, is committing $17 million over five years (2025-2030) to support the Collaborative for Equity in Cardiac Care (Collaborative), a new initiative to help advance equitable acces...